Deficiency of SCAMP5 Triggers Pancreatic β‐Cell Secretory Dysfunction and Apoptosis
Authors:
Open Access
- 15 September 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (45) , e03072
Abstract
The late stage of type 2 diabetes is characterized by secretory dysfunction and increased β‐cell apoptosis, but the underlying mechanisms are not fully understood. The expression and function of secretory carrier membrane protein 5 (SCAMP5) in β‐cells are unclear. The aim is to explore the role of SCAMP5 in diabetic β‐cell failure. SCAMP5 expression is reduced in β‐cells under diabetic conditions. Notably, SCAMP5 deficiency diminishes insulin secretion, which is involved in reduced Ca V 1.2 expression. Additionally, decreased SCAMP5 triggers β‐cell apoptosis, suggesting the anti‐apoptotic role of SCAMP5 in β‐cells. Mechanistically, SCAMP5 downregulates the protein expression of voltage‐dependent anion channel (VDAC1) and interacts with it, thereby repressing VDAC1‐recruited Bax to mitochondria, thus inhibiting the release of cytochrome c from mitochondria to the cytoplasm, culminating in preventing β‐cell apoptosis. Furthermore, hyperglycemia‐activated carbohydrate‐responsive element‐binding protein (ChREBP) epigenetically represses SCAMP5 expression by reducing trimethylation of histone H3 at lysine 4 (H3K4me3) within the Scamp5 promoter. These findings highlight the essential role of the ChREBP‐controlled SCAMP5 in β‐cell insulin secretion and apoptosis, revealing a previously unrecognized mechanism underlying the β‐cell failure in diabetes.Keywords
Funding Information
- National Natural Science Foundation of China (82070806)
- National Natural Science Foundation of China (82070845)
- National Natural Science Foundation of China (82370833)
- Natural Science Foundation of Guangdong Province (2023A1515010442)
- Natural Science Foundation of Guangdong Province (2023A1515012688)
This publication has 24 references indexed in Scilit:
- Deficiency of SCAMP5 leads to pediatric epilepsy and dysregulation of neurotransmitter release in the brainHuman Genetics, 2020
- Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expressionMolecular Metabolism, 2019
- Effect of CAPE-pNO2 against type 2 diabetes mellitus via the AMPK/GLUT4/ GSK3β/PPARα pathway in HFD/STZ-induced diabetic miceEuropean Journal of Pharmacology, 2019
- Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β CellsCell Metabolism, 2019
- Sweet Sixteenth for ChREBP: Established Roles and Future GoalsCell Metabolism, 2017
- Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse isletsThe International Journal of Biochemistry & Cell Biology, 2013
- Oligomerization of the Mitochondrial Protein VDAC12013
- Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicityDiabetologia, 2012
- Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosisAtherosclerosis, 2011
- Secretory carrier membrane proteinsProtoplasma, 2011